Skip to main content
. 2014 Apr 3;15(4):5699–5716. doi: 10.3390/ijms15045699

Table 2.

Bioactivity of OHD and OHG.

Classification Compound Bioactivity Ref.
Anticancer-Related Activity 3′-OHG Antiproliferative activity toward T47D tumorigenic breast epithelial cells; [52,53]

8-OHD Increases life span against S180 bearing mice; [43]
Suppression of MDR in Caco-2 colon adenocarcinoma cells; [58]

8-OHG Antimutagenesis activity; [36]
Antiproliferative activity toward HL-60 promyelocytic leukemia cells; [35]

6-OHD Suppression of HCT-116 colon cancer cell proliferation in vitro and in vivo; [54]

3′-OHD Suppression of EGF receptor-positive skin cancer cell proliferation in vitro and in vivo; [55,56]
Suppression of MDR transporters; [57]

Antimelanogenesis- Related Activity 6-OHD Competitive tyrosinase inhibitor; [60]

8-OHD Irreversible tyrosinase inhibitor; [61,62]
Antimelanogenesis activity in human volunteers; [63]

8-OHG Irreversible tyrosinase inhibitor; [61,62]

3′-OHD Antimelanogenesis activity in human skin equivalents; [64,65]
Potent autophage inducer; [67]

Other Bioactivities 3′-OHG HIV-1 integrase inhibitor; [25]
Antiinflammatory activity; [68]
Hepatoprotective activity; [24]

6-OHG Hepatoprotective activity; [46]

8-OHD Aldose reductase inhibitor; [69]

6-OHD Suppression on adipogenesis of 3T3-L1 preadipocytes; [70]
Promoting differentiation of 3T3-L1 preadipocytes; [71]
Antitrypanosomal activity [72]

3′-OHD Antitrypanosomal activity; [72,73]
Improving atopic dermatitis symptoms; [74]